HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


McNeil Seeks Supreme Court Opinion On OTC Labeling Pre-emption

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare argues in a consumer injury lawsuit that the Supreme Court's 2009 decision in Wyeth v. Levine does not apply to nonprescription pharmaceuticals because OTC and Rx drugs are covered by different regulatory labeling schemes.

You may also be interested in...

Supreme Court Again Asked To Address Generic Firms' Liability For Inadequate Warning Labels

Actavis is making a second appeal to the Supreme Court to consider whether a generic manufacturer can be sued for failing to add safety information to its labeling that is not in the brand's label

High Court’s Wyeth v. Levine Ruling Returns Pre-Emption Status Quo

The Supreme Court's ruling in Wyeth v. Levine dashes pharmaceutical industry hopes for broad protection from state product liability lawsuits, but is not expected to trigger a sea-change in current industry operations

Tort Attorneys Concerned By State Claim Pre-emption Described In OTC Rule

An FDA proposed rule has a lawyer's group concerned the agency is moving toward a policy of pre-empting state tort law regarding liability claims linked to over-the-counter products


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts